Normative Data of Brain Network Activation in Adolescents and Young Adults
NCT ID: NCT01460394
Last Updated: 2019-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2011-10-31
2012-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Normative Data of Brain Network Activation in Adolescents and Young Adults
NCT01671761
Normative Data of Brain Network Activation
NCT01742858
Normative Data Base of Brain Network Activation (BNA) Using Evoked Response Potentials
NCT02418208
Additional Post Hoc Analysis and Clinical Data Collection
NCT02860416
Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
NCT03699514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The need of objective measures that will help the clinician in its decision making in brain-related pathologies is recognized. BNA is a new imaging modality that has been developed to fill this gap.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy adolescents and young adults
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to participate and able to give informed assent (child) and/or consent (parent for minors or adult 18+ years of age for self).
Exclusion Criteria
* Currently with lice, open wounds on scalp.
* Any chronic disease.
* Any psychiatric disorder, e.g., depression, bipolar disorder, schizophrenic disorder, etc.
* Any CNS neurologic disorder, e.g., epilepsy, seizures, etc.
* Any neuropsychological disorders, e.g.: ADHD, Autistic Spectrum Disorder (ASD), etc.
* History of Special education, e.g., reading disorder (dyslexia), writing disorder (dysgraphia), math disorder (dyscalculia), nonverbal learning disorder.
* History of any medication affecting CNS within the last 3 months, e.g., antidepressants, anticonvulsants, psychostimulants, first generation antihistamines, etc.
* Substance abuse in the last 3 months.
* Significant sensory deficits, e.g., deafness or blindness.
* History of any brain trauma.
15 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ElMindA Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bradley D. Vince, D.O.
Role: PRINCIPAL_INVESTIGATOR
Vince and Associates Clinical Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vince and Associates Clinical Research
Overland Park, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ELM-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.